A case of recurrent Caffey's disease treated with naproxen

Clinical Orthopaedics and Related Research

Volumn 323, Issue , 1996, Pages 304-309

  Thometz, John G ^a,b   DiRaimondo, Carl A ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b Midwest Athletes Against Childhood Cancer Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN; PROSTAGLANDIN E; PROSTAGLANDIN INHIBITOR;

ARTICLE; CAFFEY DISEASE; CASE REPORT; FEMALE; HUMAN; HYPEROSTOSIS; IMMUNOSUPPRESSIVE TREATMENT; INFANT; OSSIFICATION; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 0030022123     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199602000-00043     Document Type: Article

References (21)

1. Benz-Bohm G, Emons D, Schickendantz S, et al: Cortical hyperostoses after long-term prostaglandin E2 therapy. Radiologue 24:72-78, 1984.
2. Berthier M, Bonneau D, Huret JL: Caffey disease responding to high-dose immunoglobin. (Letter) European J Pediatr 147:443-444, 1988.
3. Blank E: Recurrent Caffey's cortical hyperostosis and persistent deformity. Pediatrics 55:856-860, 1975.
4. Borochowitz Z, Gozal D, Misselevitch I, Aunallah J, Boss JH: Familial Caffey's disease and late recurrence in a child. Clin Genet 40:329-355, 1991.
5. Caffey J: On some late skeletal changes in chronic Infantile Cortical Hyperostosis. Radiology 59:651-657, 1952.
6. Caffey J: Infantile Cortical Hyperostosis: A review of the clinical and radiographic features. Proc Royal Soc Med 50:347-354, 1956.
7. Dekel S, Francis MJ: Cortical hyperostosis after administration of prostaglandin E. (Letter) J Pediatr 99:500-501, 1981.
8. Finsterbush A, Rang M: Infantile Cortical Hyperostosis. Follow-up of 29 cases. Acta Orthop Scand 46:727-736, 1975.
9. Frana L, Sekauina M: Infantile Cortical Hyperostosis. Arch Dis Child 51:589-594, 1976.
10. Heyman E, Lavar J, Beer S: Prostaglandin synthetase inhibitor in Caffey disease. (Letter) J Pediatr 101:314, 1982.
11. Jackson DR, Lyne ED: Infantile Cortical Hyperostosis. Case Report. J Bone Joint Surg 61A:770-772, 1979.
12. Jones ET, Hensinger RN, Holt HF: Idiopathic cortical hyperostosis. Clin Orthop 163: 210-213, 1982.
13. Langewisch WH: Letter: Infantile Cortical Hyperostosis - Familial occurrence in a mother and daughter. J Pediatr 87:323-324, 1975.
14. Letts M, Pang E, Simons J: Prostaglandin-induced neonatal periostitis. J Pediatr Orthop 14:809-813, 1994.
15. Medical Economics: Physicians' Desk Reference. Ed 49. Montvale, Medical Economics Data Production Co 2478-2480, 1995.
16. Pajewski M, Vure E: Late manifestations of Infantile Cortical Hyperostosis (Caffey's Disease). Br J Radiol 40:90-95, 1967.
17. Pazzagalia UE, Byers PD, Beluffi G, et al: Pathology of Infantile Cortical Hyperostosis (Caffey's Disease). J Bone Joint Surg 67A:1417-1426, 1985.
18. Rethmeier JW: Infantile Cortical Hyperostosis (Caffey's Disease) Two case reports. Radiologie Clinica 45:251-257, 1976.
19. Swerdloff BA, Ozonoff MB, Gyepes MT: Late recurrences of Infantile Cortical Hyperostosis (Caffey's Disease). American Journal of Roentgenology, Radium Therapy and Nuclear Medicine 108: 461-472, 1970.
20. Taj-Eldin S, Al-Jawad J: Cortical hyperostosis. Infantile and juvenile manifestations in a boy. Arch Dis Child 46:565-566, 1971.
21. Ueda K, Saito A, Nakano H, et al: Cortical hyperostosis following long-term administration of prostaglandin E in infants with cyanotic congenital heart disease. J Pediatr 97:834, 1980.